Phenylthiourea-Conjugated BODIPY as an Efficient Photosensitizer for Tyrosinase-Positive Melanoma-Targeted Photodynamic Therapy
- 24 November 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 4 (3) , 2120-2127
Abstract
Melanoma is the most threatening form of metastatic skin cancer that develops from melanocytes and causes a large majority of deaths due to poor therapeutic prognosis. It has significant limitations in treatment because it shows great resistance to chemotherapy, radiotherapy, and other therapeutic methods. A noninvasive and clinically accepted therapeutic modality, photodynamic therapy (PDT), is a promising treatment option, but it is limitedly applied for melanoma skin cancer treatment. This is because most of the photosensitizers are unlikely to be expected to have a remarkable effect on melanoma due to drug efflux by melanin pigmentation and intrinsic antioxidant defense mechanisms. Moreover, melanin is a dominant absorber in the spectral region of 500–600 nm that can cause the decreased photoreaction efficiency of photosensitizers. Herein, to overcome these drawbacks, we have developed a phenylthiourea-conjugated BODIPY photosensitizer (PTUBDP) for tyrosinase-positive melanoma-targeted PDT. In light of our results, it exhibited an enhanced cytotoxic efficacy compared to BDP, a parallel PDT agent that absence of phenylthiourea unit. PTUBDP shows outstanding effects of increased oxidative stress by an enhanced cellular uptake of the tyrosinase positive melanoma cell line (B16F10). This work presents increased therapeutic efficacy through the combined therapeutic approach, enabling enhanced reactive oxygen species (ROS) generation as well as overcoming the critical limitations of melanoma.Keywords
This publication has 46 references indexed in Scilit:
- Melanoma resistance to photodynamic therapy: new insightsBiological Chemistry, 2013
- Dye−Polyelectrolyte Layer-by-Layer Self-Assembled Materials: Molecular Aggregation, Structural Stability, and Singlet Oxygen PhotogenerationACS Applied Materials & Interfaces, 2010
- Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapyThe FASEB Journal, 2010
- Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients?Annals of Surgical Oncology, 2008
- TRPM8 activation suppresses cellular viability in human melanomaAmerican Journal of Physiology-Cell Physiology, 2008
- Stimulation of melanogenesis by scoparone in B16 melanoma cellsActa Pharmacologica Sinica, 2006
- Molecular diagnostics in melanomaJournal of the American Academy of Dermatology, 2005
- Tyrosinase, the Key Enzyme in Melanin Synthesis, is Expressed in Murine BrainEuropean Journal of Biochemistry, 1996
- Photodynamic Effects of Hypericin on Lipid Peroxidation and Antioxidant Status in Melanoma CellsPhotochemistry and Photobiology, 1996
- Photodynamic Therapy of Human Malignant Melanoma Xenografts in Athymic Nude Mice1JNCI: Journal of the National Cancer Institute, 1988